0000000001235791

AUTHOR

Sabrina Giometto

showing 1 related works from this author

Sensitivity of three commercial tests for SARS-CoV-2 serology in children: an Italian multicentre prospective study

2022

Abstract Background US Food and Drug Administration has issued Emergency Use Authorizations for hundreds of serological assays to support Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) diagnosis. The aim of this study is to evaluate, for the first time in children, the performance of three widely utilized SARS-CoV-2 serology commercial assays, Diesse Diagnostics (IgG, IgA, IgM) and Roche Diagnostics, both Roche Nucleocapsid (N) IgG and Roche Spike (S) IgG assays. Methods Sensitivity and 95% confidence intervals (CIs) were estimated for each of the three different serological tests and mixed and direct comparison were performed. Univariate and multivariate Poisson regression mo…

SARS-CoV-2COVID-19; Children; Electrochemiluminescent immunoassay (ECLIA); Enzyme-linked immunosorbent assay (ELISA); SARS-CoV-2Electrochemiluminescent immunoassay (ECLIA)Enzyme-linked immunosorbent assay (ELISA)COVID-19General MedicineUnited StatesImmunoglobulin AImmunoglobulin MImmunoglobulin GCOVID-19 Children Electrochemiluminescent immunoassay (ECLIA) Enzyme-linked immunosorbent assay (ELISA) SARS-CoV-2HumansProspective StudiesChildChildren
researchProduct